| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.05 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.079 | 0.05 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.33 | 0.06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.12 | 0.06 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.06 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.087 | 0.06 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.06 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.07 |